The inflammatory indicators in the tracheobronchial aspirate (TA) of 81 ventilated preterm infants with microbial colonisation of the airways and in noncolonised neonates were analysed on the first day of life. TA was assessed for chemotactic activity, neutrophil cell count, and concentrations of leukotriene B4, CSa, interleukin-1, interleukin-8, elastase-atlproteinase inhibitor, free elastase and albumin. Concentrations of mediators were related to concentrations ofthe secretory component of IgA.
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The infants' gestational age was mean (SD) 27-9 (2.0) weeks, birthweight 945 (179) g. In 12 infants (15%) microbial colonisation of the airways was present (Ureaplasma urealyticum n=7; bacteria n= 5). Compared with non-colonised neonates (n=69), chemotactic activity, neutrophil count, and concentrations of interleukin-1, leukotriene B4 and elastaseotl-proteinase inhibitor were significantly higher in the colonised group. The difference was most pronounced for IL-1 concentrations, both with and without correction for secretory component. There was also a trend towards increased concentrations of interleukin-8 in the latter group. There were no differences for concentrations of C5a and albumin in the TA of both groups.
It is concluded that airway colonisation with U urealyticum or bacteria at birth is associated with a clinically relevant bronchopulmonary inflammatory response. Increased concentrations of interleukin-l in TA on the first day of life may be a marker of perinatal colonisation of the airways. The possible impact of tracheobronchial colonisation with micro-organisms at birth on the respiratory morbidity of preterm infants has not yet been clarified. Neonatal pneumonia is a well described cause of respiratory insufficiency.' However, clinically and radiologically, it is often difficult to distinguish pneumonia from hyaline membrane disease. Additionally, in perinatal infections bacteria are often isolated from different sites of the neonate, and a positive culture in the airways might reflect simple aspiration of contaminated amniotic fluid.
Perinatal infections with Ureaplasma urealyticum have been associated with prolonged respiratory dependency and the development of bronchopulmonary dysplasia.2 3 However, the clinical relevance of U urealyticum detectable in airway fluids for the development of subsequent lung disease has been questioned.4 Growth of ureaplasma in tracheobronchial aspirates may also reflect aspiration of amniotic fluid. A study of the inflammatory response of the airways would permit a description of the interactions between microorganisms and host immune factors.
The response of neonatal airways to microbial colonisation has only partly been characterised. Increased numbers of neutrophils have been found in the tracheobronchial aspirates of newborns with perinatal infection of the airways. [5] [6] [7] To characterise the inflammatory response, the chemotactic activity of TA, neutrophil count, and concentrations of inflammatory mediators were evaluated in infants with tracheal cultures positive for bacteria or Ureaplasma, and in infants with no growth of these micro-organisms in TA.
When aspiration of the airways was indicated clinically, tracheobronchial aspirate was collected three times during the first 24 hours of life. Tracheobronchial aspiration was performed by instillation of 0 5 ml 0-9% NaCl into the endotracheal tube. Suction catheters were inserted slightly beyond the distal tip of the tube; lung and airway secretions were suctioned and collected in sterile specimen traps (Vigon, Ecouen, France). TA was diluted with 09% saline to a total volume of 0 5 ml, centrifuged at 3000 rpm for 5 minutes, and cell free supernatant fluids were frozen at -30°C for later assays. Over 24 hours, one specimen was obtained in each eight hour period. Immediately before the biochemical analysis of TA, the three samples from one day were pooled.
Specimens for U urealyticum were obtained during suctioning of the trachea within one hour of birth. The suction catheter was attached to a sterile mucus trap. For transport to the laboratory, the specimens were then put into a Ureaplasma culture medium. Specimens were inoculated onto A-7 Ureaplasma differential agar plates. Specimens were also inoculated into a fluid medium (U-9). The inoculated plates and tubes were incubated anaerobically for five days and were observed for growth every 24-48 hours. Ureaplasma was identified by colonial morphology (plates) or urease activity (tubes). The transport medium, the A-7 agar, and the U-9 medium were prepared by the laboratory.
Specimens for bacteriological cultures were obtained within the first hour of life. The suction catheter was attached to a sterile mucus trap. The specimens were transported to the laboratory within the trap, and cultures were performed using blood and MacConkey agar plates.
After centrifugation of tracheal aspirate samples, the cells were resuspended with 150 ul of 0*9% saline, and a total white cell count was performed using a haemocytometer. A differential blood count was obtained after Pappenheim staining of a cytocentrifuged cell sample.
Assay of chemotactic activity and assays for G5a and elastase activity were performed as described before.'12 13 Assays for interleukin-1 (Quantikine; R&D Systems Inc, Minneapolis, USA, sensitivity 03 pg/ml), interleukin-8 (Amersham Corporation, Aylesbury, United Kingdom, sensitivity 4-7 pg/ml), leukotriene B4 (Amersham Corporation, Aylesbury, United Kingdom, sensitivity 6 pg/ml), elastaseax-proteinase inhibitor (Merok, Darmstadt, Germany, sensitivity 40 ng/ml) were performed according to the manufacturers' instructions.
To avoid errors resulting from the sampling procedure, concentrations of inflammatory mediators measured in TA were related to concentrations of the secretory component as the reference protein. Secretory component concentration in lung effluent fluid is independent of capillary leak and not affected by gestational or postnatal age during the first month of life.14 Assays for secretory component were performed, as described before.'2 Chemotactic activity and numbers of neutrophils in TA were not related to secretory component.
As some of the data were not normally distributed, values were expressed as median (25th-75th percentile) or as median (range). Two group comparisons were performed using the Mann Whitney U test. Significance was accepted at P<0.05. Demographic data were expressed as mean (SD). Differences in numbers of patients with detectable activity of free elastase in TA were compared between both groups using the x2 test.
Results
Mean gestational age and birthweight of all 81 patients was 27-9 (2-0) weeks and 945 (179) g. Ten infants died during the first 10 days. There were four late deaths after day 28; overall survival rate was 83%. Microbial colonisation of the airways was present in 12 patients (U urealyticum n=7, Escherichia coli n=4, Staphylococcus aureus n= 1); in 69 patients the cultures were negative. Group B streptococci were not isolated during the study period.
No differences were found in gestational age, birthweight, gender, rate of caesarean section or use of prenatal steroids between both groups. Premature rupture of membranes and maternal signs of infection were more often present in neonates with colonised airways (table 1) . RDS was diagnosed more often in the non-colonised group than in the Secretory component (mg/l) 4-8 (1-2-11-0) 5-3 (1-3-13-5) §Numbers of patients with detectable activity of free elastase/total number of patients, all other values: median (25th-75th percentile). Significant differences between the groups are indicated by *P<0.05, and **P<0.01. MD means miratory distance of peripheral blood neutrophils exposed to tracheobronchial aspirate fluid. SC: secretory component.
colonised group. In all three infants with perinatal airway colonisation and respiratory distress (suspected neonatal pneumonia) E coli were isolated from the respiratory secretions. It was not possible in these infants to distinguish the chest radiograph from RDS. The rate of BPD, and the number of infants treated with dexamethasone, were no different in either group (table 1) .
Chemotactic activity, neurophil cell count, and concentrations of LTB4, IL-1, Ea1PI, and number of infants with free elastase in TA were significantly higher in the colonised group compared with non-colonised infants (table 2) . The most pronounced difference between both groups was seen in the concentration of IL-1, which was 20-fold higher in colonised infants. The median of numbers of neutrophils was seven-fold higher in infants with infection, but variability of cell numbers was high in this group. Only infants with colonised tracheobronchial secretions had neutrophil counts exceeding 1500 cells/,ul. There was a trend towards increased concentrations of IL-8 in respiratory secretions of colonised infants (P=0 07). No differences were found between both groups in the concentrations of C5a, and albumin. Additionally, there were no differences in the concentrations of the secretory component for IgA. Within the group colonised with micro-organisms, there were no differences in concentrations of inflammatory indicators between infants colonised with U urealyticum or with bacteria (table 3) .
Discussion
In this study preterm infants with positive cultures for bacteria or U urealyticum in airway secretions on the first day of life exhibited a significant inflammatory bronchopulmonary response. Chemotactic activity, numbers of neutrophils, and concentrations of interleukin-1, leukotriene B4, and Ea1PI were increased in tracheobronchial secretions compared with non-colonised neonates.
IL-1 is one of the most important cytokines regulating the inflammatory response.15 It is released locally by alveolar macrophages after stimulation with bacterial toxins or during phagocytosis of micro-organisms. In animal models intratracheal instillation of endotoxin induces an intra-alveolar inflammatory reaction composed of a neutrophilic exudate peaking at 6-12 hours, a monocytic exudate peaking at 24 hours, and a lymphocyte exudate that peaked at 48 hours. The kinetics and magnitude of this sequence were reproduced by intratracheal injection of IL-116 and blocked by IL-1-receptor antagonist.'7 Gram positive bacteria initiate macrophage activation by lipoteichoic acid.18 The mechanism of macrophage activation by micro-organisms without a cell wall, such as U urealyticum, has not been identified yet. In children with bacterial pulmonary infections increased IL-1 concentrations are found in bronchoalveolar washings.19 Our study also pinpointed substantially increased concentrations of IL-I in only slightly higher in colonised neonates compared with the non-colonised group, and there was no difference for C5a. These chemoattractants may also be generated in larger amounts within the airways following other stimuli like barotrauma or oxygen toxicity during mechanical ventilation for RDS.28
As a result of increased chemotactic activity of respiratory fluids neutrophils are attracted into the airways. In our study neutrophil count was higher in TA with perinatal colonisation. This has been described by others.5-7 Activated neutrophils release elastase, which is bound by aol-proteinase inhibitor and antileucoprotease present in the respiratory fluid. In this study elastase-cxl-proteinase inhibitor concentrations were significantly higher in infants with colonised secretions than in infants with sterile airway fluid. Free elastase was also more frequently present in the TA of infants with airway colonisation. Increased amounts of elastase al-proteinase inhibitor have been found in the tracheal secretions of newborns with bacterial airway colonisation.9 In half of the patients with pneumonia free functional extracellular elastase was found that was not bound to ao-proteinase inhibitor.30 Additionally, free elastase was detected in the TA of patients with cystic fibrosis and colonisation with Pseudomonas aeruginosa,21 and in long term ventilated infants with BPD and nosocomial airway infection.31 The presence of free elastase in TA has been associated with increased early respiratory morbidity in preterm infants with RDS. 32 Increased concentrations of inflammatory mediators have also been found in tracheal secretions of infants with BPD. 12 33 During the development of this disease, airway inflammation did not seem to be related to infection, but rather, to unspecific lung injury from oxygen toxicity and barotrauma. The concentrations of mediators in TA were lower than those found in infected secretions studied here.'3 In another study airway infection at birth was associated with the development of WilsonMikity syndrome.'0 The impact of microbial colonisation of the airways during mechanical ventilation on the development of neonatal chronic lung diseases should be evaluated in further studies.
In conclusion, this study has shown that preterm infants with positive cultures for bacteria or U urealyticum in airway secretions on the first day of life exhibit a significant inflammatory bronchopulmonary response, with evidence for local macrophage activation, neutrophil recruitment into the airways, and increased secretion of neutrophil products. However, as not all of these infants had respiratory symptoms, the results do not allow us to distinguish between a local host response against colonisation and bronchopulmonary infection. An increased concentration of interleukin-1 in the TA on the first day of life may be a marker of perinatal colonisation of the airways. 
